Home / Inspections / 1305404

FDA Inspection 1305404 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 2377733

The FDA completed an inspection of Octapharma Plasma, Inc. on February 6, 2026 in Gretna, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 6, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Gretna, LA (United States)

Facility

Other inspections at this facility

  • 1106295 (NAI Thu Sep 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 983376 (NAI Thu Aug 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 868647 (NAI Thu Feb 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 779650 (NAI Mon Apr 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 621778 (NAI Thu Sep 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources